Todd Sisitsky is the President of TPG and Co-Managing Partner of TPG Capital. He also co-leads TPG Capital’s healthcare group and its investment activities in the healthcare services, pharmaceutical, and medical device sectors. Todd has played leadership roles in TPG’s investments in Adare Pharmaceuticals, Allogene Therapeutics, Aptalis, Biomet, Ellodi Pharmaceuticals, Exactech, Fenwal, Healthscope, IASIS Healthcare, Immucor, IQVIA (and predecessor companies IMS Health and Quintiles), Monogram Health, Par Pharmaceutical, and Surgical Care Affiliates. Todd is also the Chair of the Dartmouth Medical School Board of Advisors and a board member of Grassroot Soccer. Prior to joining TPG in 2003, Todd worked at Forstmann Little & Company and Oak Hill Capital Partners. He received an MBA from the Stanford Graduate School of Business and earned his undergraduate degree from Dartmouth College.